Free from Publisher

Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments

C Godin, S Dupont, Z Ezzoukhry, C Louandre… - Anticancer …, 2013 - ar.iiarjournals.org
Background/Aim: Sorafenib is currently the only medical treatment with proven efficacy
against hepatocellular carcinoma (HCC). HCC cell lines display heterogeneous sensitivity to …
被引用次数：17 相关文章
[PDF] iiarjournals.org

[PDF][PDF] Heterogeneous Sensitivity of Hepatocellular Carcinoma to Sorafenib Revealed by the Short-term Culture of Tumor Fragments

C GODIN, S DUPONT, Z EZZOUKHRY… - ANTICANCER …, 2013 - ar.iiarjournals.org
Background/Aim: Sorafenib is currently the only medical treatment with proven efficacy
against hepatocellular carcinoma (HCC). HCC cell lines display heterogeneous sensitivity to …
[PDF] psu.edu

[PDF][PDF] Heterogeneous Sensitivity of Hepatocellular Carcinoma to Sorafenib Revealed by the Short-term Culture of Tumor Fragments

C GODIN, S DUPONT, Z EZZOUKHRY… - ANTICANCER …, 2013 - Citeseer
Background/Aim: Sorafenib is currently the only medical treatment with proven efficacy
against hepatocellular carcinoma (HCC). HCC cell lines display heterogeneous sensitivity to …

Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments

C Godin, S Dupont, Z Ezzoukhry… - Anticancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Background/aim Sorafenib is currently the only medical treatment with proven efficacy
against hepatocellular carcinoma (HCC). HCC cell lines display heterogeneous sensitivity to …

Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments.

C Godin, S Dupont, Z Ezzoukhry, C Louandre… - Anticancer …, 2013 - europepmc.org
Materials and methods Using experimental tumors generated in nude mice, we set up a
technique for short-term culture of HCC fragments. We applied this technique to six human …